Friedrich Finckenstein

Company: IOVANCE Biotherapeutics, Inc.

Job title: CMO

Seminars:

Industry Leaders Fireside Chat: Challenges & Opportunities in Expanding Beyond Melanoma 8:30 am

What is the current state on developing TILs for indications beyond melanoma? What are key hurdles that must be overcome to apply TILs to more diverse indications? How do we evaluate what indications are most suitable to target with TILs? What are some key opportunities and breakthroughs in applying TILs to uncharted indications?Read more

day: Conference Day One